Adding diabetes pills to insulin for type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at whether adding oral diabetes medications to insulin therapy can help people with type 1 diabetes manage their blood sugar better. It compares people who take both insulin and oral drugs with those who take only insulin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have type 1 diabetes.
- You have had an HbA1c test result of 7% or higher (this is a blood test that shows your average blood sugar over the past few months).
- You are currently taking oral diabetes medications along with insulin, or you are taking only insulin.
- You have been on your current treatment plan for at least 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if adding a non-insulin medication can lower the amount of insulin needed while improving heart and metabolic health in people with type 1 diabetes. It may also help understand how this approach works in people with a genetic form of diabetes (GCK-MODY).
This study tests whether adding certain diabetes pills (GLP-1 receptor agonists or SGLT inhibitors) to insulin is safe and helpful for adults with type 1 diabetes. Doctors will check your glucose monitor data to see how well this works.
This study tests whether adding a sodium-glucose cotransporter-2 inhibitor (SGLT2i), a thiazolidinedione (TZD), or a combination of both to your current DPP4 inhibitor-based treatment can improve blood sugar control in type 2 diabetes. It aims to find the best add-on option for people who need extra help managing their diabetes.
This study tests whether adding a diabetes pill called pioglitazone to your current treatment (which includes an SGLT2 inhibitor and insulin) can lower your HbA1c (average blood sugar) further and prevent a dangerous rise in blood ketones, a byproduct that can cause serious complications. If it works, this combination may help improve blood sugar control in people with type 1 diabetes.
This study tests whether a new injection that combines insulin with liraglutide works better than standard premixed insulin for people with type 2 diabetes. It aims to improve blood sugar control and simplify treatment.
This trial is testing if adding a combination of SGLT-2 inhibitor and GLP-1 receptor agonist to metformin can improve blood sugar control in people with type 2 diabetes who are not meeting their goals on metformin alone or with one other pill.
Hear when a new Type 1 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.